Nephros to Present at Zooming with LD

Rhea-AI Summary

Nephros, a commercial-stage company specializing in high-performance water purification and pathogen detection systems, announces its participation in the upcoming Zooming with LD event on July 23rd, 2020, at 11:00 AM ET. Daron Evans, President & CEO, and Andy Astor, COO & CFO, will present and address investor inquiries. Interested parties can register for the virtual presentation through the provided link. Nephros's products, including ultrafilters and pathogen detection systems, enhance infection control and water quality across various markets, including healthcare and food service.

SOUTH ORANGE, N.J., July 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will be presenting virtually at the upcoming Zooming with LD event on Thursday, July 23^rd at 11:00 AM ET. Daron Evans, President & CEO and Andy Astor, COO & CFO of Nephros will be giving the presentation and answering questions from investors.

Investors and other individuals may access the virtual presentation by registering here: https://calendly.com/ldmicromeetings/nephrospresentation, and clicking on July 23^rd to receive the Zoom link.

About Nephros

Nephros is a commercial-stage company that develops and markets high performance water purification products and pathogen detection systems for medical and commercial markets.

Nephros ultrafilters are used in hospitals, medical clinics, and commercial facilities to retain bacteria and viruses from water, providing barriers that aid in infection control for showers, sinks, and ice machines. Nephros ultrafilters are also used in dialysis centers to aid in the removal of endotoxins and other biological contaminants from water and bicarbonate concentrate in hemodialysis machines. 

Nephros pathogen detection systems, including the PluraPath™, SequaPath™, and DialyPath™ systems, provide data on water-borne biological content to medical and water quality professionals. Our products integrate Nephros ultrafilters with quantitative polymerase chain reaction (qPCR) technology to deliver actionable water pathogen information in real time.

Nephros commercial filters, including AETHER™ brand filters, improve the taste and odor of water, and reduce scale build-up in downstream equipment. Nephros and AETHER™ products are used in the health care, food service, hospitality, and convenience store markets.

For more information about Nephros, please visit its website at www.nephros.com.

Contacts:

Investor Relations:
Kirin Smith, President
PCG Advisory, Inc.
(646) 863-6519
ksmith@pcgadvisory.com
www.pcgadvisory.com

Media Relations:
Bill Douglass
Gotham Communications, LLC
(646) 504-0890
bill@gothamcomm.com
www.gothamcomm.com

Company:
Andy Astor, COO & CFO
Nephros, Inc.
(201) 345-0824
andy@nephros.com
www.nephros.com

FAQ

When is Nephros presenting at the Zooming with LD event?

Nephros will present at the Zooming with LD event on July 23rd, 2020, at 11:00 AM ET.

Who will represent Nephros at the Zooming with LD event?

Daron Evans, President & CEO, and Andy Astor, COO & CFO, will represent Nephros at the event.

How can I access the Nephros virtual presentation?

You can access the Nephros virtual presentation by registering at the provided link and selecting July 23rd for the Zoom link.

What products does Nephros specialize in?

Nephros specializes in high-performance water purification products and pathogen detection systems for medical and commercial markets.

What markets benefit from Nephros's ultrafilters?

Nephros's ultrafilters are used in hospitals, medical clinics, dialysis centers, and commercial facilities to enhance infection control and water quality.